OLIG-1 and 2 gene expression and oligodendroglial tumours

Neuropathology and Applied Neurobiology

Volumn 28, Issue 2, 2002, Pages 89-94

  Hoang Xuan, K ^a   Aguirre Cruz, L ^a   Mokhtari, K ^a   Marie, Y ^a   Sanson, M ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Differentiation; Glioblastoma; OLIG 1; OLIG 2; Oligodendrocyte; Oligodendroglial tumours; Oligodendroglioma

Indexed keywords

BRAIN PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMEODOMAIN PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN NGN2; PROTEIN NKX2 2; PROTEIN OLIG 1; PROTEIN OLIG 2; PROTEOLIPID PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CARCINOGENESIS; CELL STRUCTURE; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOTONEURON; NONHUMAN; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR DIAGNOSIS;

EID: 0036230481     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2002.00395.x     Document Type: Article

References (40)

1. Sonic hedgehog is required during an early phase of oligodendrocyte development in mammalian brain
2. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
3. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
4. The biology of astrocytoma: Lessons learned from chronic myelogenous leukemia - Hypothesis
5. Improving diagnostic accuracy and inter-observer concordance in the classification and grading of primary gliomas
6. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
7. Oligodendrogliomas. Part I. Patterns of growth, histological diagnosis, clinical and imaging correlations. A study of 153 cases
8. Oligodendroglioma. An appraisal of recent data pertaining to diagnosis and treatment
9. Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading
10. Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF alpha-receptors
11. Glioblastomas with an oligodendroglial component: A pathological and molecular study
12. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
13. Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis
14. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas
15. Pathology and genetics. Tumours of the nervous system
16. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma
17. Expression of oligodendrocytic mRNAs in glial tumors: Changes associated with tumor grade and extent of neoplastic infiltration
18. Glioma classification: A molecular reappraisal
19. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system
20. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors
21. Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex
22. Molecular genetic evidence for subtypes of oligoastrocytomas
23. OLIG2 as a specific marker of oligodendroglial tumour cells
24. Cracking the transcriptional code for cell specification in the neural tube
25. Combinatorial roles of olig2 and neuro-genin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons
26. Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2
27. Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor
28. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
29. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade 'oligodendroglioma'
30. Expression of oligodendrocyte progenitor cell antigens by gliomas. Implications for the histogenesis of brain tumors
31. Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features
32. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype
33. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligo-astrocytomas
34. Sonic hedgehog dependent emergence of oligodendrocytes in the telencephalon: Evidence for a source of oligodendrocytes in the olfactory bulb independent on PDGFRa signaling
35. Olig bHLH proteins interact with homeo-domain proteins to regulate cell fate acquisition in progenitors of the ventral neural tube
36. Glycolipids and myelin proteins in human oligodendrogliomas
37. Dynamic expression of basic helix-loop-helix Olig family members. Implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3
38. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors
39. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2
40. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms